ASX - By Stock
|
LU7 |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
34 |
12K |
11 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
34
|
12K
|
11
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
34 |
12K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
34
|
12K
|
3
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
43 |
24K |
6 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
43
|
24K
|
6
|
|
ASX - By Stock
|
FIN |
Re:
Ann: Exceptionally High-Grade Lithium Confirmed at Cancet West
|
|
Bigbigal
|
32 |
13K |
4 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
Bigbigal
|
156 |
49K |
46 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
156
|
49K
|
46
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Bigbigal
|
450 |
145K |
26 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
26
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
Bigbigal
|
25 |
8.2K |
1 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
25
|
8.2K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
Bigbigal
|
25 |
8.2K |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
25
|
8.2K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
Bigbigal
|
25 |
8.2K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
25
|
8.2K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
General discussion
|
|
Bigbigal
|
7 |
1.9K |
1 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
7
|
1.9K
|
1
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
49 |
15K |
14 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
49
|
15K
|
14
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
20 |
5.1K |
8 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
20
|
5.1K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Bigbigal
|
151 |
55K |
29 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
151
|
55K
|
29
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Assays Confirm 19m Thick Copper Mineralised Zone at Austin
|
|
Bigbigal
|
228 |
55K |
3 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
228
|
55K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Executes Contracts to Commence Breast Cancer Trial
|
|
Bigbigal
|
53 |
19K |
6 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
53
|
19K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Cardioprotection Ethics Trial Approval
|
|
Bigbigal
|
27 |
10K |
38 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
27
|
10K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
Bigbigal
|
22 |
6.3K |
25 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
22
|
6.3K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Melbourne Investor Briefing Invitation
|
|
Bigbigal
|
70 |
24K |
22 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
70
|
24K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Response to ASX Price Query
|
|
Bigbigal
|
20 |
10K |
38 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
20
|
10K
|
38
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Suspension from Official Quotation
|
|
Bigbigal
|
75 |
20K |
4 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
75
|
20K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Bigbigal
|
1.6K |
573K |
5 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
1.6K
|
573K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Bigbigal
|
48 |
15K |
5 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
48
|
15K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Bigbigal
|
48 |
15K |
4 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
48
|
15K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bigbigal
|
20K |
7.0M |
37 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
20K
|
7.0M
|
37
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bigbigal
|
20K |
7.0M |
10 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
20K
|
7.0M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene shows synergy with kinase inhibitors in melanoma
|
|
Bigbigal
|
45 |
20K |
25 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
45
|
20K
|
25
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bigbigal
|
20K |
7.0M |
8 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
20K
|
7.0M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bigbigal
|
20K |
7.0M |
21 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
20K
|
7.0M
|
21
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Bigbigal
|
2.0K |
671K |
28 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
2.0K
|
671K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Becoming a substantial holder
|
|
Bigbigal
|
50 |
16K |
5 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
50
|
16K
|
5
|
|
ASX - By Stock
|
GED |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
112 |
34K |
4 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
112
|
34K
|
4
|
|
ASX - By Stock
|
GED |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
112 |
34K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
112
|
34K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
Bigbigal
|
115 |
42K |
7 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
42K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
Bigbigal
|
115 |
42K |
17 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
42K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race raises $29.7 million in oversubscribed SPP
|
|
Bigbigal
|
378 |
99K |
33 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
378
|
99K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Bigbigal
|
386 |
131K |
31 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
131K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Bigbigal
|
386 |
131K |
34 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
131K
|
34
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bigbigal
|
20K |
7.0M |
31 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
20K
|
7.0M
|
31
|
|
ASX - By Stock
|
RAD |
Re:
IPO - Radiopharm Theranostics Limited - 25 November 2021 11:00 AM AEDT ##
|
|
Bigbigal
|
88 |
39K |
2 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
88
|
39K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
Bigbigal
|
557 |
157K |
15 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
557
|
157K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
218 |
66K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
218
|
66K
|
1
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Response to ASX Price Query
|
|
Bigbigal
|
76 |
18K |
1 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
76
|
18K
|
1
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Response to ASX Price Query
|
|
Bigbigal
|
76 |
18K |
3 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
76
|
18K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race-Chaim Sheba FTO Biomarker Collaboration
|
|
Bigbigal
|
124 |
32K |
14 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
124
|
32K
|
14
|
|
ASX - By Stock
|
NVA |
Re:
cap raise
|
|
Bigbigal
|
272 |
79K |
3 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
272
|
79K
|
3
|
|
ASX - By Stock
|
EMC |
Re:
Ann: Lithium and Tin Targets Identified at Trident Project, NSW
|
|
Bigbigal
|
172 |
58K |
1 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
172
|
58K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Outlook for MXC
|
|
Bigbigal
|
306 |
151K |
6 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
306
|
151K
|
6
|
|
ASX - By Stock
|
CAP |
Re:
Ann: Trading Halt
|
|
Bigbigal
|
277 |
74K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
277
|
74K
|
1
|
|
ASX - By Stock
|
ILA |
Re:
Chart
|
|
Bigbigal
|
37 |
11K |
5 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
37
|
11K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race investor briefing & updated presentation
|
|
Bigbigal
|
334 |
87K |
3 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
334
|
87K
|
3
|
|